What's so special about methadone maintenance?

References

• Dole VP, Nyswander ME. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. J Am Med Ass 1965; 193: 646–650
   PubMed Web of Science ®Google Scholar
• Action Committee Against Narcotics. Hong Kong Narcotics Report for 1981. Government Printer, Hong Kong 1983; 169–169
   Google Scholar
• Gunne L, Grönbladh L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend 1981; 7: 249–256
   PubMed Web of Science ®Google Scholar
• Scordata M. 1967–82, un bilancio dell'espereienza svedese sulla terapia di mantenimento dei morfinodipendenti con il methadone. Minerva Med 1982; 73: 3353–3358
   Google Scholar
• Pfersmann, D, Presslich, O, Pakesch, G, et al. Gestaltung und Durchführung des österreichischen Methadonprogrammes und erste Ergebnisse. Nervenarzt 1990; 61: 438–443
   PubMedGoogle Scholar
• Déglon JJ. Evaluation d'un programme de traitement des heroïnomanes par la methadone. Psychotropes 1988; 4: 31–37
   Google Scholar
• Fuchs WJ. Möglichkeiten und Grenzen der Substitutions-Behandlung in der AIDS-Prävention. Z Allg Med 1989; 65: 61–64
   Google Scholar
• Krach, C, Lotze, J, Peschke, H, et al. Ambulantes Therapieprogramm mit Methadon. Niedersächsisches Ärztebl 1978; 51: 289–292
   Google Scholar
• Schlömer H. Von der Methadondiskussion zur Praxis: Darstellung und Einschätzung der Modellversuche in Nordrhein-Westfalen und Hamburg. Akzeptierende Drogenarbeit, K Schuller, H Stöver. Lambertus, FreiburgGermany 1990; 128–128, In
   Google Scholar
• Stadtgesundheitsamt Frankfurt a.M.: Ambulanz für Austiegshilfen: Erster Erfahrungsbericht, Januar 1989–Juni 1990. Stadt Frankfurt am Main, FrankfurtGermany September, 1990
   Google Scholar
• Walger, P, Baumgart, P, Wilke, G, et al. Medizinische und Psychosoziale Effekte der Methadon-Substitution HIV-Infizierter Drogenabhängiger. Psychother Psychosom Med Psychol 1989; 39: 381–389
   PubMedGoogle Scholar
• Reynolds I, Magro D. The use of methadone as a treatment tool for opiate addicts: a two-year follow-up study. Med J Aust 1976; 2: 560–562
   PubMed Web of Science ®Google Scholar
• Abdul-Quader, AS, Friedman, SR, DesJarlais, D, et al. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemp Drug Probl 1987; 14: 425–434
   Google Scholar
• Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Hlth Soc Behav 1988; 29: 214–226
   PubMed Web of Science ®Google Scholar
• Brown LS, Jr, Burkett W, Primm BJ. Drug treatment and HIV seropositivity [Letter]. NY State J Med 1988; 88: 156–156
   PubMedGoogle Scholar
• Hubbard, RL, Marsden, ME, Cavanaugh, E, et al. Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis 1988; 10: 377–384
   PubMedGoogle Scholar
• Novick, DM, Joseph, H, Croxson, TS, et al. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med 1990; 150: 97–99
   PubMed Web of Science ®Google Scholar
• Schuster CR. Substance abuse J Am Med Ass 1987; 258: 2269–2271
   Google Scholar
• Serraino D, Francheschi S. Methadone maintenance programmes and AIDS [Letter]. Lancet 1989; ii: 1522–1523
   Google Scholar
• Tidone L, Sileo F, Goglio A, Borra GC. AIDS in Italy. Am J Drug Alcohol Abuse 1987; 13: 485–486
   PubMed Web of Science ®Google Scholar
• Eidesgenössische Betäubungsmittelkommission. Methadonbericht2nd ed. Bundesamt für Gesundheitswesen, Bern 1989; 31–31
   Google Scholar
• Blix O, Grönbladh L (1988) AIDS and the IV heroin addict: the preventive effect of methadone maintenance in Sweden [Abstract]. Proceedings of the Fourth International Conference on AIDS. June, 12–161988, 8548–8548, In Book II Stockholm
   Google Scholar
• Kolar, AF, Brown, BS, Weddington, WW, et al. A treatment crisis: cocaine use by clients in methadone maintenance programs. J Subst Abuse Treat 1990; 7: 101–107
   PubMed Web of Science ®Google Scholar
• Joseph H, Dole VP. Methadone patients on probation and parole. Fed Probation 1970; 34: 42–48
   Google Scholar
• Newman RG, Kagen J. The New York City Methadone Maintenance Treatment Program After Two Years—An Overview. Proceedings of the Fifth National Conference on Methadone Treatment. NAPAN, New York 1973; 794–801, In
   Google Scholar
• Newman RG. Narcotic addiction and methadone treatment in Hong Kong: lessons for the United States. J Publ Hlth Policy 1985; 6: 526–538
   PubMedGoogle Scholar
• Schuster CR. Methadone maintenance—an adequate dose is vital in checking the spread of AIDS. NIDA Notes 1989; 4: 3–3, Spring/Summer 33
   Google Scholar
• Dole VP, Nyswander ME. Rehabilitation of patients on methadone programs. Proceedings of the Fifth National Conference on Methadone Treatment. National Association for the Prevention of Addiction to Narcotics, New York 1973; 1–7, In
   Google Scholar
• Newman RG. Methadone treatment in narcotic addiction. Academic Press, New York 1977; 64–64
   Google Scholar
• Grönbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 1990; 82: 223–227
   PubMed Web of Science ®Google Scholar
• Spady v. Mount Vernon Housing Authority, 41, App. Div. 762 2d Department. 1973
   Google Scholar
• Temporary State Commission to Evaluate the Drug Laws. Employing the Rehabilitated Addict. N.Y. State Legislative Doc. No. 10 1973; 49–49
   Google Scholar
• Obuchowsky M, Zweben JE. Bridging the gap: the methadone client in 12-step programs. J Psychoactive Drugs 1987; 19: 301–302
   PubMed Web of Science ®Google Scholar
• Newman RG. The Need to redefine addiction. N Engl J Med 1983; 308: 1096–1098
   PubMed Web of Science ®Google Scholar
• Ledda, F, Blandina, P, Botti, P, et al. Overall evaluation of treatment modalities for heroin addiction in a toxicology unit. Subst Alcohol Actions/Misuse 1983; 4: 283–304
   Google Scholar
• Newman RG, Whitehill WB. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet 1979; ii: 485–488
   Google Scholar
• NIDA Establishes Division of Medications Development: New Unit Seeks to Expand Drug Abuse Treatments. NIDA Notes 1990; 5: 26–27, 30
   Google Scholar
• Moynihan DP. Yes, We Do Need a ‘Methadone Clone’. New York Times Feb., 1989; 23–23, 26
   Google Scholar
• Committee on Judiciary, United States Senate. Pharmacotherapy: A Strategy for the 1990's, Staff Report. U.S. Government Printing Office, Washington D.C. December, 1989, 13
   Google Scholar
• United States General Accounting Office. Methadone Maintenance. Publication No. GAO/HRD-90–104. March, 1990
   Google Scholar
• Treating Drug Problems, Vol. 1, DR Gerstein, HJ Harwood. National Academy Press, Washington, D.C. 1990; 13: 153–153
   Google Scholar
• Office of Technology Assessment, United States Congress. The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection. Office of Technology Assessment, Washington, D.C. September, 1990; 5–5
   Google Scholar
• Newman RG. Advocacy for methadone treatment. Ann Intern Med 1990; 113: 819–820
   PubMed Web of Science ®Google Scholar